Tavaborole topical solution recalled from three lots because of discoloration
Viona Pharmaceuticals is recalling 13,080 bottles of Tavaborole Topical Solution 5% across three lots because of discoloration.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 as a product appearance defect: the record cites discoloration only, with no hazard or reported harm.
Plain-English summary
Tavaborole Topical Solution 5%, in 10 mL bottles, manufactured by Zydus Lifesciences in Ahmedabad, India and distributed by Viona Pharmaceuticals of Cranford, New Jersey, is being recalled for discoloration.
The recall covers 13,080 bottles from lots T400819 and T400820, expiring 30 April 2026, and lot T401969, expiring 30 September 2026, carrying NDC 72578-102-04. The product was distributed nationwide in the United States. The FDA has classified the recall as Class II.
The enforcement record states the discoloration without describing a health consequence, and reports no injuries.
Patients holding an affected lot should contact their pharmacy or prescriber about a replacement.
The recalled product
- Product
- TAVABOROLE (TAVABOROLE)
- Brand
- TAVABOROLE
- Manufacturer
- VIONA PHARMACEUTICALS INC
- Category
- Drug — Topical antifungal
- Affected units
- 13,080
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot#: T400819
- T400820
- Exp 4/30/26
- T401969
- Exp 9/30/26
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TAVABOROLE
- ModerateTavaborole topical solution recalled after discoloration found in one lot
FDA (Drugs) · 2025-08-27
Same manufacturer · VIONA PHARMACEUTICALS INC
See all →- HighDapsone Topical Gel Recalled Due to Crystallization Defect
FDA (Drugs) · 2025-01-08
- ModerateDapsone Gel Recalled Nationwide for Crystallization
FDA (Drugs) · 2025-01-08
- ModerateDapsone Gel 7.5% recalled nationwide due to crystallization
FDA (Drugs) · 2024-11-13
- ModeratePrescription Dapsone Gel 7.5% Recalled Due to Crystallization
FDA (Drugs) · 2024-10-23
- SevereMetformin Hydrochloride Extended-Release Tablets Recalled for NDMA Contamination
FDA (Drugs) · 2022-02-02
Same hazard · discoloration
See all →- ModerateFresenius NaturaLyte Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateFresenius Citrasate Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29